Header Logo

Connection

KATIE MATATALL to Chemoradiotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications KATIE MATATALL has written about Chemoradiotherapy, Adjuvant.
KATIE MATATALL
Connection Strength
0.023
Chemoradiotherapy, Adjuvant
  1. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res. 2012 Jan 15; 18(2):408-16.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.